| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 2 | +50.00% | +1.30% | +0.71% | +0.58% | +0.58% | — |
| 14d | 2 | +50.00% | +6.15% | +0.81% | +5.34% | +5.34% | — |
| 30d | 2 | +100.00% | -12.81% | -3.42% | -9.39% | -9.39% | — |
| 60d | 2 | +100.00% | -18.85% | -9.88% | -8.97% | -8.97% | — |
| 90d | 2 | +100.00% | -5.23% | -0.30% | -4.93% | -4.93% | — |
| 180d | 2(1 pending) | +0.00% | +31.76% | +5.20% | +26.56% | +26.56% | — |
| 1y | 2(1 pending) | +100.00% | -76.88% | +14.37% | -91.25% | -91.25% | — |
| 2y | 2(2 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| TLPH TALPHERA, INC. | PURCHASEGRANT Stock grant | 30,700 | — | — | 30,700 | Jun 22, 2026 | Jun 24, 2026 ↗ | View → |
| TLPH TALPHERA, INC. | PURCHASEGRANT Stock grant | 5,100 | — | — | 13,647 | Jun 22, 2026 | Jun 24, 2026 ↗ | View → |
| ATYR ATYR PHARMA INC | SALE Chief Financial Officer | 1,558 | $0.98 | $1.5K | 37,296 | Feb 4, 2026 | Feb 4, 2026 ↗ | View → |
| ATYR ATYR PHARMA INC | PURCHASE Chief Financial Officer | 3,750 | — | — | 38,854 | Feb 3, 2026 | Feb 4, 2026 ↗ | View → |
| ATYR ATYR PHARMA INC | SALE Chief Financial Officer | 3,750 | — | — | 0 | Feb 3, 2026 | Feb 4, 2026 ↗ | View → |
| ATYR ATYR PHARMA INC | PURCHASEGRANT Stock grant | 412,500 | — | — | 412,500 | Jan 9, 2026 | Jan 9, 2026 ↗ | View → |
| CUE CUE BIOPHARMA, INC. | PURCHASEGRANT Stock grant | 24,400 | — | — | 24,400 | Jan 2, 2026 | Jan 6, 2026 ↗ | View → |
| TLPH TALPHERA, INC. | PURCHASEGRANT Stock grant | 4,267 | — | — | 8,547 | Oct 23, 2025 | Oct 24, 2025 ↗ | View → |
| TLPH TALPHERA, INC. | PURCHASEGRANT Stock grant | 25,600 | — | — | 25,600 | Oct 23, 2025 | Oct 24, 2025 ↗ | View → |
| CUE CUE BIOPHARMA, INC. | PURCHASEGRANT Stock grant | 48,800 | — | — | 48,800 | Jun 4, 2025 | Jun 6, 2025 ↗ | View → |
| ATYR ATYR PHARMA INC | SALE Chief Financial Officer | 1,254 | $3.78 | $4.7K | 31,763 | Feb 4, 2025 | Feb 4, 2025 ↗ | View → |
| ATYR ATYR PHARMA INC | SALE Chief Financial Officer | 3,750 | — | — | 3,750 | Feb 3, 2025 | Feb 4, 2025 ↗ | View → |
| ATYR ATYR PHARMA INC | PURCHASE Chief Financial Officer | 3,750 | — | — | 33,017 | Feb 3, 2025 | Feb 4, 2025 ↗ | View → |
| ATYR ATYR PHARMA INC | PURCHASEGRANT Stock grant | 275,000 | — | — | 275,000 | Jan 8, 2025 | Jan 10, 2025 ↗ | View → |
| TLPH TALPHERA, INC. | PURCHASEGRANT Stock grant | 2,174 | — | — | 4,280 | Jun 24, 2024 | Jun 24, 2024 ↗ | View → |
| TLPH TALPHERA, INC. | PURCHASEGRANT Stock grant | 13,044 | — | — | 13,044 | Jun 24, 2024 | Jun 24, 2024 ↗ | View → |
| LIFE ETHOS TECHNOLOGIES INC. | PURCHASE Chief Financial Officer | 5,000 | $1.79 | $8.9K | 27,960 | May 31, 2024 | Jun 3, 2024 ↗ | View → |
| LIFE ETHOS TECHNOLOGIES INC. | SALE Chief Financial Officer | 1,590 | $1.69 | $2.7K | 20,821 | Feb 6, 2024 | Feb 6, 2024 ↗ | View → |
| LIFE ETHOS TECHNOLOGIES INC. | SALE Chief Financial Officer | 3,750 | — | — | 7,500 | Feb 5, 2024 | Feb 6, 2024 ↗ | View → |
| LIFE ETHOS TECHNOLOGIES INC. | PURCHASE Chief Financial Officer | 3,750 | — | — | 22,411 | Feb 5, 2024 | Feb 6, 2024 ↗ | View → |
| LIFE ETHOS TECHNOLOGIES INC. | PURCHASEGRANT Stock grant | 150,000 | — | — | 150,000 | Jan 5, 2024 | Jan 9, 2024 ↗ | View → |
| LIFE ETHOS TECHNOLOGIES INC. | PURCHASEGRANT Stock grant | 84,023 | — | — | 84,023 | Feb 16, 2023 | Feb 21, 2023 ↗ | View → |
| LIFE ETHOS TECHNOLOGIES INC. | SALE Chief Financial Officer | 1,566 | $2.36 | $3.7K | 15,460 | Feb 6, 2023 | Feb 6, 2023 ↗ | View → |
| LIFE ETHOS TECHNOLOGIES INC. | PURCHASE Chief Financial Officer | 3,750 | — | — | 17,026 | Feb 3, 2023 | Feb 6, 2023 ↗ | View → |
| LIFE ETHOS TECHNOLOGIES INC. | SALE Chief Financial Officer | 3,750 | — | — | 11,250 | Feb 3, 2023 | Feb 6, 2023 ↗ | View → |
| LIFE ETHOS TECHNOLOGIES INC. | PURCHASEGRANT Stock grant | 75,347 | — | — | 75,347 | May 24, 2022 | May 26, 2022 ↗ | View → |
| LIFE ETHOS TECHNOLOGIES INC. | PURCHASEGRANT Stock grant | 30,000 | — | — | 30,000 | Feb 3, 2022 | Feb 7, 2022 ↗ | View → |
| LIFE ETHOS TECHNOLOGIES INC. | PURCHASEGRANT Stock grant | 15,000 | — | — | 15,000 | Feb 3, 2022 | Feb 7, 2022 ↗ | View → |
| LIFE ETHOS TECHNOLOGIES INC. | PURCHASE Chief Financial Officer | 1,923 | $6.75 | $13.0K | 12,112 | Jan 13, 2022 | Jan 18, 2022 ↗ | View → |
| LIFE ETHOS TECHNOLOGIES INC. | PURCHASEGRANT Stock grant | 54,000 | — | — | 54,000 | May 21, 2021 | May 25, 2021 ↗ | View → |
| LIFE ETHOS TECHNOLOGIES INC. | SALE Chief Financial Officer | 390 | $7.66 | $3.0K | 9,833 | Feb 9, 2021 | Feb 9, 2021 ↗ | View → |
| LIFE ETHOS TECHNOLOGIES INC. | PURCHASE Chief Financial Officer | 892 | — | — | 10,223 | Feb 6, 2021 | Feb 9, 2021 ↗ | View → |
| LIFE ETHOS TECHNOLOGIES INC. | SALE Chief Financial Officer | 892 | — | — | 0 | Feb 6, 2021 | Feb 9, 2021 ↗ | View → |
| LIFE ETHOS TECHNOLOGIES INC. | PURCHASEGRANT Stock grant | 50,000 | — | — | 50,000 | Feb 4, 2021 | Feb 8, 2021 ↗ | View → |
| LIFE ETHOS TECHNOLOGIES INC. | PURCHASE Chief Financial Officer | 1,850 | $4.22 | $7.8K | 9,153 | Jun 19, 2020 | Jun 23, 2020 ↗ | View → |
| LIFE ETHOS TECHNOLOGIES INC. | PURCHASEGRANT Stock grant | 30,000 | — | — | 30,000 | May 26, 2020 | May 28, 2020 ↗ | View → |
| LIFE ETHOS TECHNOLOGIES INC. | SALE Chief Financial Officer | 375 | $4.03 | $1.5K | 7,125 | Feb 7, 2020 | Feb 7, 2020 ↗ | View → |
| LIFE ETHOS TECHNOLOGIES INC. | SALE Chief Financial Officer | 893 | — | — | 893 | Feb 6, 2020 | Feb 7, 2020 ↗ | View → |
| LIFE ETHOS TECHNOLOGIES INC. | PURCHASE Chief Financial Officer | 893 | — | — | 7,500 | Feb 6, 2020 | Feb 7, 2020 ↗ | View → |
| LIFE ETHOS TECHNOLOGIES INC. | PURCHASEGRANT Stock grant | 23,359 | — | — | 23,359 | Feb 5, 2020 | Feb 7, 2020 ↗ | View → |